Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology Read more →
GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program Read more →
FDA flags concerns for AstraZeneca's camizestrant, Truqap ahead of advisory committee meeting Read more →
« All Events
February 5, 2025 @ 8:30 am
The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.